Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications

Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT(1) and MT(2) melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pandi-Perumal, Seithikurippu R., Spence, D. Warren, Verster, Joris C., Srinivasan, Venkatramanujam, Brown, Gregory M., Cardinali, Daniel P., Hardeland, Rüdiger
Format: Artigo
Idioma:Inglês
Publicat: Libertas Academica 2011
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663615/
https://ncbi.nlm.nih.gov/pubmed/23861638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCNSD.S1611
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars